Georgia Capital Shareholder and Market Opportunity Overview

GEL MILLION AGGREGATED REVENUE DEVELOPMENT ACROSS PRIVATE LARGE PORTFOLIO COMPANIES RESILIENT PERFORMANCE OF HEALTHCARE SERVICES, NET REVENUE UP 23.3% Y-O-Y IN 1Q21. LTM 1Q21 NET REVENUE UP 3.8% Y-O-Y +20.7% +23.3% 89 74 72 +3.8% 300 289 GEL MILLION ӨӨ GEORGIA CAPITAL 1Q21 REVENUE OF RETAIL (PHARMACY) REMAINED LARGELY FLAT (DOWN 0.7% Y-O-Y). LTM 1Q21 REVENUE UP 5.3% Y-O-Y +19.2% -0.7% 175 174 146 +5.3% 678 644 1Q19 Healthcare Services¹ KEY DRIVERS 1Q20 1Q21 LTM 1Q20 LTM 1021 The number of admissions was up by 26.2% y-o-y at clinics and up by 22.9% y-o-y at hospitals in 1Q21. The Healthcare services business has mobilised c.1,000 beds across the country to treat COVID-19 patients, as needed. The diagnostics business more than tripled its quarterly revenue in 1Q21 y-o-y to GEL 5.5 million. Georgia Capital PLC | 1. Revenues from Medical Centre University Clinic (HTMC) are excluded for the presentation purposes. 1Q19 1Q20 1Q21 LTM 1Q20 LTM 1Q21 ■Retail (Pharmacy) KEY DRIVERS A slight decline in the 1Q21 revenue mainly reflects the base effect of the significant customer stockpiling of pharmaceuticals at the onset of the pandemic in 1Q20 and the decreased demand for flu and other seasonal medicines over the last few months. Average bill size up 17.1% y-o-y to GEL 18.4 in 1Q21. 31

View entire presentation